Jasper Therapeutics, Inc. - Common Stock, $0.001 Par Value (JSPR)

Historical Holders from Q4 2023 to Q3 2025

Symbol
JSPR on Nasdaq
CUSIP
471871202
Type / Class
Equity / Common Stock, $0.001 Par Value
Shares outstanding
27.9M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
20.2M
Holdings value
$47.8M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
60
Number of buys
31
Number of sells
-37
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Jasper Therapeutics, Inc. - Common Stock, $0.001 Par Value (JSPR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Velan Capital Investment Management LP 9.6% $7.58M 2.67M Velan Capital Investment Management LP Sep 19, 2025
T. Rowe Price Investment Management, Inc. 7.1% $4.9M 2.06M T. Rowe Price Investment Management, Inc. Sep 30, 2025
ACORN BIOVENTURES, L.P. 6.4% $4.16M 1.79M Anders Hove Dec 1, 2025
Soleus Capital Master Fund, L.P. 9.96% $5.41M 1.49M Soleus Capital Management, L.P. Dec 31, 2024
KINGDON CAPITAL MANAGEMENT, L.L.C. 4.7% -8% $3.15M $1.33M 1.32M +73.2% Kingdon Capital Management, L.L.C. Sep 30, 2025
Qiming U.S. Healthcare Fund II, L.P. 3.3% $2.21M 929K Qiming U.S. Healthcare Fund II, L.P. Sep 30, 2025
MORGAN STANLEY 2.8% -44% $1.87M $62.3K 785K +3.45% Morgan Stanley Sep 30, 2025
BlackRock, Inc. 1.5% $1.02M 226K BlackRock, Inc. Jun 30, 2025

Institutional Holders of Jasper Therapeutics, Inc. - Common Stock, $0.001 Par Value (JSPR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 20.2M $47.8M +$13.4M $2.38 60
2025 Q2 12.5M $69.5M -$2.54M $5.55 63
2025 Q1 13M $56M -$70.6M $4.30 66
2024 Q4 15.6M $334M +$15M $21.38 84
2024 Q3 14.7M $275M -$5.49M $18.81 77
2024 Q2 14.6M $330M +$34.9M $22.70 68
2024 Q1 13M $379M +$359M $29.36 56
2023 Q4 495K $390K +$390K $0.79 1